Trading Statements
![shutterstock_528756874.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_528756874.jpg)
Trading Statement Q4, 2024
20 Jan 2025
![shutterstock_255383656.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_255383656.jpg)
Trading Statement Q3, 2024
18 Okt 2024
![shutterstock_421890220.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_421890220.jpg)
Trading Statement Q2, 2024
19 Jul 2024
![shutterstock_443123731.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_443123731.jpg)
Trading Statement Q1, 2024
19 Apr 2024
![shutterstock_516311050.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_516311050.jpg)
Trading Statement Q4, 2023
19 Jan 2024
![shutterstock_599785391.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_599785391.jpg)
Trading Statement Q3, 2023
20 Okt 2023
![shutterstock_12373195.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_12373195.jpg)
Q2, 2023 Trading Statement
20 Jul 2023
![shutterstock_566626918.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_566626918.jpg)
Trading Statement Q1, 2023
21 Apr 2023
![shutterstock_631274768.jpg](/globalassets/investor-relations/public/generic-ineos-imagery/shutterstock_631274768.jpg)
Trading Statement Q4, 2022
03 Feb 2023